REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,714,937 | -27.7% | 141,965 | -36.7% | 0.00% | – |
| Q2 2023 | $2,373,391 | +1067.6% | 224,328 | +985.9% | 0.00% | – |
| Q1 2023 | $203,275 | -93.3% | 20,658 | -90.0% | 0.00% | -100.0% |
| Q4 2022 | $3,028,466 | -40.0% | 205,878 | -50.5% | 0.00% | 0.0% |
| Q3 2022 | $5,049,000 | +32.7% | 416,276 | +53.1% | 0.00% | 0.0% |
| Q2 2022 | $3,805,000 | +56.5% | 271,920 | +59.3% | 0.00% | – |
| Q1 2022 | $2,431,000 | +54.8% | 170,727 | +129.4% | 0.00% | – |
| Q4 2021 | $1,570,000 | -19.6% | 74,413 | -0.0% | 0.00% | – |
| Q3 2021 | $1,953,000 | -72.0% | 74,449 | -66.8% | 0.00% | -100.0% |
| Q2 2021 | $6,984,000 | +604.0% | 224,000 | +593.0% | 0.00% | – |
| Q1 2021 | $992,000 | +150.5% | 32,322 | +179.8% | 0.00% | – |
| Q4 2020 | $396,000 | +63.0% | 11,552 | +46.1% | 0.00% | – |
| Q3 2020 | $243,000 | -65.3% | 7,906 | -65.0% | 0.00% | – |
| Q2 2020 | $700,000 | – | 22,565 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $32,989,176 | 13.80% |
| CHI Advisors LLC | 2,800,126 | $41,189,854 | 10.97% |
| MPM BioImpact LLC | 1,639,849 | $24,122,179 | 6.26% |
| BVF INC/IL | 8,291,988 | $121,975,143 | 5.15% |
| Deep Track Capital, LP | 2,727,606 | $40,123,084 | 1.68% |
| Redmile Group, LLC | 2,684,396 | $39,487,465 | 1.62% |
| HighVista Strategies LLC | 164,890 | $2,425,532 | 1.44% |
| Orbimed Advisors | 3,322,488 | $48,873,798 | 0.94% |
| Artal Group S.A. | 700,000 | $10,297 | 0.58% |
| HARBOR CAPITAL ADVISORS, INC. | 34,572 | $508,554 | 0.49% |